Japanese Survey of Adverse Reaction by Hematopoietic Cell Transplantation

Japanese Survey of Adverse Reaction by Hematopoietic Cell Transplantation - Survey of Adverse Reaction by Hematopoietic Cell Transplantation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000011646

Enrollment

1000

Registered

2013-09-05

Start date

2013-09-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hematologic malignancies and bone marrow failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who will require autologous peripheral blood stem cell transplantation (PBSCT) or donors for allogeneic PBSCT will be eligible if they undergo PBSCH. Written informed consent is required, and enrollees should be 18 years or older.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Numbers of infused cells and types and frequencies of adverse reactions.	—

Countries

Japan

Contacts

Public ContactKazuhiko Ikeda

Fukushima Medical University Department of Blood Transfusion and Transplantation Immunology

kazu-ike@fmu.ac.jp024-547-1536

Outcome results